About
Bob Balch joined Cycad Group in 2004 and has helped found and finance companies across stages, serving as a director or board observer for portfolio companies such as ClarVista Medical, Iosil Energy, Lixivia, Sofie, SteriFx, SpectraFluidics and Agile RF. He previously co-founded Taraval Associates Seed Capital Fund, an early-stage life sciences venture fund, and held operating roles in healthcare startups and telecommunications, including as General Manager of Mark Products.
Invests in
BiotechDigital HealthEnergyMedical Devices
Investments
Board seats
Agile RFClarVista MedicalIosil EnergyLixiviaSofieSpectraFluidicsSteriFx
Per the firm's website.
